Exposure of the U.S. population to acrylamide in the National Health and Nutrition Examination Survey 2003-2004

Environmental Health Perspectives

Volumn 118, Issue 2, 2010, Pages 278-283

  Vesper, Hubert W ^a   Caudill, Samuel P ^a   Osterloh, John D ^a   Meyers, Tunde ^a   Scott, Deanna ^a   Myers, Gary L ^a  

^a NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

Author keywords

Acrylamide; Biomonitoring; Glycidamide; Hemoglobin adducts; Human exposure; NHANES; U.S. Population

Indexed keywords

ACRYLAMIDE; COTININE; GLYCIDAMIDE; HEMOGLOBIN; TOBACCO SMOKE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GROUPS BY AGE; HEALTH HAZARD; HUMAN; MALE; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RACE DIFFERENCE; SCHOOL CHILD; SEX DIFFERENCE; SMOKING; UNITED STATES;

ACRYLAMIDE; ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; ENVIRONMENTAL EXPOSURE; EPOXY COMPOUNDS; FEMALE; HEALTH SURVEYS; HEMOGLOBINS; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; YOUNG ADULT;

NICOTIANA TABACUM;

EID: 77149127048     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.0901021     Document Type: Article

References (56)

1. Bartsch H, Nair U, Risch A, Rojas M, Wikman H, Alexandrov K. 2000. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9:3-28.
2. Bjellaas T, Olesen PT, Frandsen H, Haugen M, Stolen LH, Paulsen JE, Alexander J, et al. 2007. Comparison of estimated dietary intake of acrylamide with hemoglobin adducts of acrylamide and glycidamide. Toxicol Sci 98:110-117.
3. Bolt HM, Roos PH, Thier R. 2003. The cytochrome P-450 isoenzyme CYP2E1 in the biological processing of industrial chemicals: consequences for occupational and environmental medicine. Int Arch Occup Environ Health 76:174-185.
4. CDC (Centers for Disease Control and Prevention). 2009. National Health and Nutrition Examination Survey. Available: http://www.cdc.gov/nchs/nhanes.htm [accessed 26 July 2009].
5. Chevolleau S, Jacques C, Canlet C, Tulliez J, Debrauwer L. 2007. Analysis of hemoglobin adducts of acrylamide and glycidamide by liquid chromatography-electrospray ionization tandem mass spectrometry, as exposure biomarkers in French population. J Chromatogr A 1167:125-134.
6. Duale N, Bjellaas T, Alexander J, Becher G, Haugen M, Paulsen JE, et al. 2009. Biomarkers of human exposure to acrylamide and relation to polymorphisms in metabolizing genes. Toxicol Sci 108:90-99.
7. Dybing E, Farmer PB, Andersen M, Fennell TR, Lalljie SPD, et al. 2005. Human exposure and internal dose assessments of acrylamide in food. Food Chem Toxicol 43:365-410.
8. Exon JH. 2006. A review of the toxicology of acrylamide. J Toxicol Environ Health 9:397-412.
9. FDA (U.S. Food and Drug Administration). 2006. The U.S. FDA 2006 Exposure Assessment for Acrylamide [slide presentation (Robie D, DiNovi M)]. Available: www.fda.gov/ohrms/dockets/ac/03/slides/3925s1-Dr.%20Robie.ppt [accessed 26 July 2009].
10. Fennell TR, Sumner SC, Snyder RW, Burgess J, Spicer R, Bridson WE, et al. 2005. Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol Sci 85:447-459.
11. Fennell TR, Sumner SC, Walker VE. 1992. A model for the formation and removal of hemoglobin adducts. Cancer Epidemiol Biomarkers Prev 1:213-219.
12. Gamboa da Costa G, Churchwell MI, Hamilton LP, Beland FA, Marques MM, Doerge DR. 2003. DNA adduct formation from acrylamide via conversion to glycidamide in adult and neonatal mice. Chem Res Toxicol 16:1328-1337.
13. Ghanayem BI, Witt KL, El-Hadri L, Hoffler U, Kissling GE, Shelby MD, et al. 2005a. Comparison of germ cell mutagenicity in male CYP2E1-null and wild-type mice treated with acrylamide: evidence supporting a glycidamide-mediated effect. Biol Reprod 72:157-163.
14. Ghanayem BI, Witt KL, Kissling GE, Tice RR, Recio L. 2005b. Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-effect. Mutat Res 578:284-297.
15. Greim H, Snyder R, eds. 2008. Toxicology and Risk Assessment: A Comprehensive Introduction. Chichester, UK:John Wiley & Sons.
16. Hagmar L, Törnqvist M, Nordander C, Rosén I, Bruze M, Kautiainen A, et al. 2001. Health effects of occupational exposure to acrylamide using hemoglobin adducts as biomarkers of internal dose. Scand J Work Environ Health 27:219-226.
17. Hagmar L, Wirfalt E, Paulsson B, Tornqvist M. 2005. Differences in hemoglobin adduct levels of acrylamide in the general population with respect to dietary intake, smoking habits and gender. Mutat Res 580:157-165.
18. Hartmann EC, Boettcher MI, Schettgen T, Fromme H, Drexler H, Angerer J. 2008. Hemoglobin adducts and mercapturic acid excretion of acrylamide and glycidamide in one study population. J Agric Food Chem 56:6061-6068.
19. Heudorf U, Hartmann E, Angerer J. 2008. Acrylamide in children-exposure assessment via urinary acrylamide metabolites as biomarkers. Int J Hyg Environ Health 212:135-141.
20. Hornung RW, Reed LD. 1990. Estimation of average concentration in the presence of nondetectable values. Appl Occup Environ Hyg 5:46-51.
21. IARC (International Agency for Research on Cancer). 1995. Acrylamide. IARC Monogr Eval Carcinog Risk Hum 60:1-45.
22. Ingelman-Sundberg M, Johansson I, Persson I, Oscarson M, et al. 1994. Genetic polymorphism of cytochrome P450. Functional consequences and possible relationship to disease and alcohol toxicity. EXS 71:197-207.
23. Itoga S, Nomura F, Makino Y, Tomonaga T, Shimada H, Ochiai T, et al. 2002. Tandem repeat polymorphism of the CYP2E1 gene: an association study with esophageal cancer and lung cancer. Alcohol Clin Exp Res 26:15S-19S.
24. Jones K, Garfitt S, Emms V, Warren N, Cocker J, Farmer P. 2006. Correlation of haemoglobin-acrylamide adducts with airborne exposure: an occupational survey. Toxicol Lett 162:174-180.
25. Klaunig JE. 2008. Acrylamide carcinogenicity. J Agric Food Chem 56:5984-5988.
26. Korn EL, Graubard BI. 1998. Confidence intervals for proportions with small expected number of positive counts estimated from survey data. Surv Methodol 24:193-201.
27. Kütting B, Uter W, Drexler H. 2008. The association between self-reported acrylamide intake and hemoglobin adducts as biomarkers of exposure. Cancer Causes Control 19:273-281.
28. LoPachin RM, Barber DS, Gavin T. 2008. Molecular mechanisms of conjugated a,b-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative disease. Toxicol Sci 104:235-249.
29. Manjanatha MG, Aidoo A, Shelton SD, Bishop ME, McDaniel LP, Lyn-Cook LE, et al. 2006. Genotoxicity of acrylamide and its metabolite glycidamide administered in drinking water to male and female Big Blue mice. Environ Mol Mutagen 47:6-17.
30. McCarver DG, Byun R, Hines RN, Hichme M, Wegenek W. 1998. A genetic polymorphism in the regulatory sequences of human CYP2E1: association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake. Toxicol Appl Pharmacol 152:276-281.
31. Mosteller RD. 1987. Simplified calculation of body-surface area. N Engl J Med 317:1098.
32. Mottram DS, Wedzicha BL, Dodson AT. 2002. Acrylamide is formed in the Maillard reaction. Nature 419:448-449.
33. Mowrer, J, Tornqvist M, Jensen S, Ehrenberg L. 1986. Modified Edman degradation applied to hemoglobin for monitoring occupational exposure to alkylating agents. Toxicol Environ Chem 11:215-231.
34. Mucci LA, Wilson KM. 2008. Acrylamide intake through diet and human cancer risk. J Agric Food Chem 56:6013-6019.
35. NTP (National Toxicology Program). 2004. NTP-CERHR Expert Panel Report on the Reproductive and Developmental toxicity of Acrylamide. Available: http://cerhr.niehs.nih.gov/chemicals/acrylamide/final-report.pdf [accessed 24 July 2009].
36. Ogawa M, Oyama T, Isse T, Yamaguchi T, Murakami T, Endo Y, et al. 2006. Hemoglobin adducts as a marker of exposure to chemical substances, especially PRTR class I designated chemical substances. J Occup Health 48:314-328.
37. Olesen PT, Olsen A, Frandsen H, Frederiksen K. 2008. Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish diet, cancer and health study. Int J Cancer 122:2094-2100.
38. Osterman-Golkar S, Czene K, Lee MS, Faller TH, Csanády GA, et al. 2003. Dosimetry by means of DNA and hemoglobin adducts in propylene oxide-exposed rats. Toxicol Appl Pharmacol 191:245-254.
39. Osterman-Golkar SM, Vesper HW. 2006. Assessment of the relationship between glucose and A1c using kinetic modeling. J Diabetes Complications 20:285-294.
40. Paulsson B, Larsen KO, Törnqvist M. 2006. Hemoglobin adducts in the assessment of potential occupational exposure to acrylamides-three case studies. Scand J Work Environ Health 32:154-159.
41. Pirkle JL, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF. 2006. Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988-2002. Environ Health Perspect 114:853-858.
42. Scherer G, Engl J, Urban M, Gilch G, Janket D, Riedel K. 2007. Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany. Regul Toxicol Pharmacol 47:171-183.
43. Schettgen T, Rossbach B, Kutting B, Letzel S, Drexler H, Angerer J. 2004. Determination of haemoglobin adducts of acrylamide and glycidamide in smoking and nonsmoking persons of the general population. Int J Hyg Environ Health 207:531-539.
44. Shah BV, Barnwell BG, Bieler GS. 1996. SUDAAN User's Manual, Release 7. Research Triangle Park, NC:Research Triangle Institute.
45. Shipp A, Lawrence G, Gentry R, McDonald T, Bartow H, Bounds J, et al. 2006. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects. Crit Rev Toxicol 36:481-608.
46. Smith J. Perfetty TA, Rumple MA, Rodgam A, Doolittle D. 2000. "IARC group 2A carcinogens" reported in cigarette mainstream smoke. Food Chem Toxicol. 38:371-378.
47. Stadler RH, Blank I, Varga N, Robert F, Hau J, Guy PA, et al. 2002. Acrylamide from Maillard reaction products. Nature 419:449-450.
48. Svensson K, Abramsson L, Becker W, Glynn A, Hellenäs KE, Lind Y, et al. 2003. Dietary intake of acrylamide in Sweden. J Food Chem Toxicol 41:1581-1586.
49. Tareke E, Twaddle NC, McDaniel LP, Churchwell MI, Young JF, Doerge DR. 2006. Relationships between biomarkers of exposure and toxicokinetics in Fischer 344 rats and B6C3F1 mice administered single doses of acrylamide and glycidamide and multiple doses of acrylamide. Toxicol Appl Pharmacol 217:63-75.
50. USDA-ARS (U.S. Department of Agriculture, Agricultural Research Services). 2007. Nutrient Intakes: Mean Amounts Consumed per Individual, by Race/Ethnicity and Age, One Day, 2003-2004. Available: http://ars.usda.gov/ SP2UserFiles/Place/12355000/pdf/0304/Table-3-NIF.pdf [accessed 10January 2010].
51. Vesper HW, Bernert JT, Ospina M, Meyers T, Ingham L, Smith A, et al. 2007. Assessment of the relation between biomarkers for smoking and biomarkers for acrylamide exposure in humans. Cancer Epidemiol Biomarkers Prev 16:2471-2478.
52. Vesper HW, Slimani N, Hallmans G, Tjonneland A, Agudo A, Benetou V, et al. 2008. Cross-sectional study on acrylamide hemoglobin adducts in subpopulations from the European Prospective Investigation into Cancer and Nutrition (EPIC) Study. J Agric Food Chem 56:6046-6053.
53. World Health Organization. 2002. Health Implications of Acrylamide in Food Report of a Joint FAO/WHO Consultation WHO Headquarters, Geneva:World Health Organization. Available: http://www.who.int/foodsafety/publications/chem/ acrylamide-june2002/en/ [accessed 10January 2010].
54. Wilson KM, Vesper HW, Tocco P, Sampson L, Rosen J, Hellenas KE, et al. 2008. Validation of a food frequency questionnaire measurement of dietary acrylamide intake using hemoglobin adducts of acrylamide and glycidamide. Cancer Causes Control. 20:269-278.
55. Wirfält E, Paulsson B, Törnqvist M, Axmon A, Hagmar L. 2008. Associations between estimated acrylamide intakes, and hemoglobin AA adducts in a sample from the Malmö Diet and Cancer cohort. Eur J Clin Nutr 62:314-323.
56. Woodruff RS. 1952. Confidence intervals for medians and other position measures. J Am Stat Assoc 47:635-647.